Global Pain Management Devices Market to Witness 9.1% CAGR; Boston Scientific’s ‘Spectra WaveWriter’ Launch to Enable Growth
— The global pain management devices market will benefit from increasing regulatory approvals for neuromodulation devices in recent years. According to a report published by Fortune Business Insights, titled “Pain Management Devices: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,922.9 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,046.3 Mn by 2026, exhibiting a CAGR of 9.4%.
Pain management devices aid in reducing chronic pain and other undesirable conditions. Pain management can be used as an alternative to surgery to improve the result of your medication. This allows a non-invasive platform for surgical procedures, which in turn will lead to an increase in the global market value. Recent technological advancements have opened up a huge pain management devices market growth potential.
Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/pain-management-devices-market-101069
According to the Centers for Disease Control and Prevention, around 20.4% of the total population in the US suffered from chronic pain in 2016. In addition to the increasing incidence of chronic pain, increasing neuropathic conditions will contribute to the increasing pain management devices market size.
Launch of Technologically Advanced Pain Management Devices Likely to Enable Market Growth
Technological advancements in pain management devices have played a huge part in the overall pain management market growth in recent years. Several companies have launched products with better feasibility and high operational efficacy. In January 2019, Boston Scientific announced the launch of an advanced chronic pain management device, which has been identified as one of the very few devices in the Pain Management Devices Market with the ability to combine paresthesia and sub-perception therapy.
The ‘Spectra WaveWriter SCS System’ was launched with the aim of offering a non-drug therapeutic approach for people suffering from chronic pain. The report encompasses product launches, similar to Boston Scientific’s latest device and signifies the importance and impact of such devices on the global pain management devices market.
By End User
· Physiotherapy Centers
· Hospitals and Clinics
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Rest of the World
35% Rise in Regulatory Approvals for Pain Management Device Indicates a Huge Potential for Growth in the Foreseeable Future
As the benefits of pain management devices have been unfolded in recent years, there has been an increase in adoption for these devices across the world. Resulting from the increasing demand for pain management devices, there has been a gradual increase in clinical approvals for these devices in recent years.
Fortune Business Insights profiles a few of the companies that have generated substantial pain management market revenue in recent years. Some of the leading companies that are currently operating in the global pain management market are Medtronic, Boston Scientific Corporation, LivaNova, Abbott, DJO Global LLC, SPR Therapeutics, and Nevro Corp.
Buy Complete Report@ https://www.fortunebusinessinsights.com/checkout-page/101069
TABLE OF CONTENT:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Recent Industry Developments- Partnerships,Mergers, and Acquisitions
4.2. Technological Advancements in Pain ManagementDevices Market
4.3. Epidemics of Chronic Pain for Key Countries
4.4. New Product Launch by Key Players
4.5. Key Industry Trends
More Trending Topics from Future Business Insights-
Release ID: 88908576